OUR TEAM

Mini Bio

Soncini, Fernando

Group Director, Senior Researcher

Fernando Soncini is a biochemist, graduated from the Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario. He completed his Ph.D. at the Centro de Estudios Fotosintéticos y Bioquímicos and did his postdoctoral work at Washington University School of Medicine, Saint Louis, Missouri, United States. He is Senior Researcher at CONICET, and head of the Signal Transduction in Pathogenic Bacteria Group. His group’s research focuses on the analysis of the signaling mechanisms that modulate the expression of factors required by Salmonella for infection. His laboratory has discovered mechanisms used by the pathogen for copper homeostasis and biofilm formation that are required for its virulence. Dr. Soncini was an International Research Scholar of the Howard Hughes Medical Institute and Latin American Fellow of the Pew Charitable Trusts. He served as Chair of the American Society for Microbiology (ASM) Ambassadors Caucus and Member of the Moselio Schaechter Distinguished Service Award Selection Committee of the American Academy of Microbiology, among others.

He is director of the following projects: Molecular determinants of Salmonella cell-envelope copper homeostasis, NIH (R01 AI150784); Balance between resistance and virulence in the evolution of copper homeostasis in Salmonella, FONCyT (PICT-2019-2019-00982); Salmonella pathogenesis island 2 in the control of biofilm formation, FONCyT (PICT-2018-02122).

https://scholar.google.com/citations?user=9HDjdtAAAAAJ&hl=es&oi=ao

https://orcid.org/0000-0002-8925-7763

https://www.scopus.com/authid/detail.uri?authorId=6603795367

Twitter: @FerSoncini

IG: fernandosoncini

contacto@conicet.gov.ar

Sede CCT Rosario

Ocampo y Esmeralda, Predio CONICET-Rosario
2000 Rosario, Santa Fe, Argentina
Tel. 54-341-4237070 / 4237500 / 4237200

Sede Facultad de Ciencias Bioquímicas y Farmacéuticas

Universidad Nacional de Rosario - Suipacha 531
2000 Rosario, Santa Fe, Argentina
Tel. +54 341 4350596 / 4350661 / 4351235

🦠 Avance clave para hacer frente a infecciones polimicrobianas y multirresistentes.

Acinetobacter usa vesículas para desactivar antibióticos y resistir tratamientos. Este hallazgo abre nuevas vías para combatir infecciones difíciles. 🦠💊 👉 @lab_vila 👏